Clinical Trial Update: A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of sumatriptan succinate and naproxen sodium for migraine; results were posted after completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Naproxen sodium (naproxen sodium)
• Sumatriptan succinate (Sumatriptan succinate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-02-17